Medegen MMS, Inc. v. ICU Medical, Inc.

317 F. App'x 982
CourtCourt of Appeals for the Federal Circuit
DecidedNovember 20, 2008
Docket2008-1114
StatusUnpublished
Cited by3 cases

This text of 317 F. App'x 982 (Medegen MMS, Inc. v. ICU Medical, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Medegen MMS, Inc. v. ICU Medical, Inc., 317 F. App'x 982 (Fed. Cir. 2008).

Opinions

[983]*983Opinion for the court filed by Circuit Judge DYK, in which Circuit Judge RADER joins. Dissenting opinion filed by Chief District Judge WALKER.

DYK, Circuit Judge.

Plaintiff-Appellant Medegen MMS, Inc. (“Medegen”), appeals from a final order of the district court granting judgment of noninfringement to Defendant-Appellee ICU Medical, Inc. (“ICU”), with respect to claims 27-28, 31, 39, 41, 42, 47, 53-55, 59, 62, and 63 of U.S. Patent No. 5,730,418 (“the '418 patent”). See Medegen MMS, Inc. v. ICU Medical, Inc., No. 06-619 (C.D.Cal. Sept. 14, 2007). Because the district court erred in its construction of the claim term “plug,” we vacate and remand.

BACKGROUND

Medegen owns the '418 patent, entitled “Minimum Fluid Displacement Medical Connector.” The patented invention is directed to a needle-free valve for intravenous (I.V.) therapy used to administer fluids to a medical patient. In particular, the patented device connects a syringe to a catheter, for adding or removing fluids from a patient’s circulatory system.

A common problem associated with such connectors in the prior art is a phenomenon known as retrograde flow. Retrograde flow is the reverse flow of fluid out of the patient’s body and back into the catheter tubing, the connector, and the syringe, caused by the negative pressure suction that occurs as the syringe is withdrawn from the connector. Retrograde flow is undesirable because the backflow of fluid often contains blood, which causes clotting, and can impede fluid flow through the catheter. Blocked catheter tubing requires either flushing of the tube or complete replacement of the catheter.

The patented invention significantly reduces unwanted retrograde flow by compensating for the negative pressure introduced into the connector by the removal of the syringe with a positive pressure introduced by a plug. That is, as the syringe is removed from the connector, a portion of the plug slides into a valve internal chamber of the connector, thereby reducing the volume of the valve internal chamber, which in turn eliminates the pressure suction of fluid flow out of the patient’s body.

The patent discloses several embodiments having different types of plugs, which can be characterized as either a sliding-type plug, or a collapsible-type plug. The collapsible-type plug collapses like an accordion as the syringe is inserted into an inlet valve, thereby reducing the volume of the internal chamber. See, e.g., '418 patent Fig.3. The sliding-type plug, exemplified in Figures 1 and 2, includes an elastomeric proximal portion that buckles and rotates when the syringe is inserted into the inlet valve, and a distal portion that slides in and out of an air chamber, which is located at the far end of the connector. The buckling and rotation of the proximal portion of the plug creates an opening for fluid flow between an inlet valve and the valve internal chamber. The axial movement of the distal portion creates the change in volume in the internal chamber, thereby achieving a reduction of the unwanted retrograde flow.

In May 2001, Medegen brought this action against ICU, alleging infringement of the '418 patent by ICU’s CLC2000 Connector. In response, ICU asserted several affirmative defenses, including invalidity of the '418 patent. Because ICU’s invalidity defense relied on several prior art references that were not considered by the Patent Office, Medegen filed a petition seeking reexamination of the '418 patent. The Patent Office granted the petition, and [984]*984Medegen voluntarily dismissed its claims against ICU pending the outcome of the reexamination proceeding. On April 11, 2006, the Patent Office issued a Reexamination Certificate for the '418 patent, allowing claim 28 as originally drafted, ' claims 1-3, 5, 6, 16-27, and 31-32 as amended, and new claims 33-77. Mede-gen re-filed its infringement action against ICU, asserting infringement of thirteen claims of the '418 patent, including: claims 27-28, 31, 39, 41, 42, 47, 53-55, 59, 62, and 63.

Of the asserted claims, several include a “plug” limitation, several include a “biased-member” limitation, and several include a “displacing means” limitation. Claim 27 is representative of the asserted “plug” claims:

A self-flushing connector, comprising:
a valve internal chamber;
a valve inlet port adapted for receiving an actuator, the actuator having a lumen for introducing fluid through the valve inlet port and into the valve internal chamber;
a valve outlet port adapted for outputting fluid from the valve internal chamber, the valve outlet port being in fluid communication with the valve internal chamber at all times and being adapted for allowing fluid to freely flow into and out of the valve internal chamber through the valve outlet port at all times;
an air chamber; and
a plug adapted for being moved into a portion of the air chamber when the actuator is moved into the valve internal chamber and for being moved out of a portion of the air chamber when the actuator is removed from the valve internal chamber, movement of the actuator into the valve internal chamber resulting in a relatively small movement of fluid through the valve outlet port and into the valve internal chamber, and movement of the actuator out of the valve internal chamber resulting in a relatively small movement of fluid through the valve outlet port and out of the valve internal chamber.

'418 patent col.4 1.52-eol.5 1.8 (emphasis added). Asserted claims 31 and 47 have a “biased member” limitation, which the parties agree is simply a “plug” subjected to a biasing force.

Claim 28 is representative of the asserted “displacing means” claims:

A self-flushing connector, comprising:
a valve inlet port adapted for receiving an actuator in an inward direction into the valve inlet port, the actuator having a lumen for introducing fluid through the valve inlet port in the inward direction;
a valve outlet port adapted for transferring fluid in one of a first direction out of the self-flushing connector and a second direction into the self-flushing connector; and
displacing means adapted for providing displacements of fluid within the self-flushing connector, the displacing means effecting a relatively small movement of fluid through the valve outlet port in the second direction in response to movement of the actuator in the inward direction, and the displacing means effecting a relatively small movement of fluid through the valve outlet port in the first direction in response to movement of the actuator in an outward direction opposite to the inward direction.

'418 patent col. 12, 11.8-26 (emphasis added).

After a Markman hearing, the district . court issued a claim construction order, construing several of the disputed claim terms, including “plug,” biased member, [985]*985and “displacing means.” Based on its reading of the specification and the prosecution history, the district court construed the term “plug” as “an elastomeric part that either pivots about a reduced diameter portion or buckles, to establish a fluid flow path.” J.A. at 19.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
317 F. App'x 982, Counsel Stack Legal Research, https://law.counselstack.com/opinion/medegen-mms-inc-v-icu-medical-inc-cafc-2008.